DigestRedComo funciona
Red
/
Empresas
Un
No verificado

United Therapeutics Corporation

Sobre qué escribimos

BiotecnologíaCardiologíaFarmacéuticaMedicina - VariosSalud

56 Comunicados de prensa

Ver todos los comunicados de prensa
29/04/2026
Mercado laboral
Ciencia
Cardiología
Biotecnología
Medicina alternativa
Oncología
Salud
Sanidad
United Therapeutics Corporation Announces Retirement of Professor Raymond Dwek, C.B.E., F.R.S., From Its Board of Directors
Fuente
United Therapeutics Corporation
Editor
Business Wire
1.00
0
22/04/2026
Web y redes sociales
Telefonía
Finanzas
Mercado de valores
Ciencia
Cardiología
Biotecnología
Medicina - Varios
Sanidad
Salud
United Therapeutics Corporation to Report First Quarter 2026 Financial Results Before Market Open on Wednesday, May 6, 2026
Fuente
United Therapeutics Corporation
Editor
Business Wire
1.00
0
20/04/2026
Ciencia
Medicina - Varios
Cardiología
Biotecnología
Salud
Farmacéutica
Eventos
Industria
United Therapeutics Corporation Presents New Data Spanning Pulmonary Hypertension Treatment, Lung Donor Expansion, and Xenotransplantation at ISHLT 2026
Fuente
United Therapeutics Corporation
Editor
Business Wire
1.00
0
08/04/2026
Industria
Biotecnología
Farmacéutica
Salud
Cardiología
United Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation for miroliverELAP® for Treatment of Acute Liver Failure
Fuente
United Therapeutics Corporation
Editor
Business Wire
1.00
0
30/03/2026
Eventos
Industria
Salud
Medicina - Varios
Ciencia
Farmacéutica
Cardiología
Biotecnología
United Therapeutics Corporation Announces TETON-1 Pivotal Study of Tyvaso® Meets Primary Endpoint for Treatment of Idiopathic Pulmonary Fibrosis, Exceeding Impressive Treatment Effect Seen in TETON-2
Fuente
United Therapeutics Corporation
Editor
Business Wire
1.00
0
11/03/2026
Industria
Biotecnología
Salud
Farmacéutica
Medicina - Varios
Cardiología
United Therapeutics Corporation Announces Full Results of TETON-2 Phase 3 Clinical Trial Published in The New England Journal of Medicine
Fuente
United Therapeutics Corporation
Editor
Business Wire
1.00
0
09/03/2026
Finanzas
Biotecnología
Farmacéutica
Salud
Cardiología
United Therapeutics Corporation Announces $2 Billion Stock Repurchase Authorization and Enters into $1.5 Billion Accelerated Share Repurchase Program
Fuente
United Therapeutics Corporation
Editor
Business Wire
1.00
0
03/03/2026
Web y redes sociales
Eventos
Finanzas
Biotecnología
Sanidad
Salud
Farmacéutica
Cardiología
United Therapeutics Corporation to Present at the Leerink Global Healthcare Conference
Fuente
United Therapeutics Corporation
Editor
Business Wire
1.00
0
02/03/2026
Web y redes sociales
Industria
Análisis de Mercados
Ciencia
Medicina - Varios
Cardiología
Sanidad
Biotecnología
Farmacéutica
Salud
United Therapeutics Corporation Announces Ralinepag Achieved 55% Reduction in Risk of Clinical Worsening in Pivotal Pulmonary Arterial Hypertension Study, Delivering Exceptional, Highly Statistically Significant Efficacy
Fuente
United Therapeutics Corporation
Editor
Business Wire
1.00
0
25/02/2026
Web y redes sociales
Telefonía
Mercado de valores
Biotecnología
Sanidad
Salud
Farmacéutica
Cardiología
United Therapeutics Corporation Reports Fourth Quarter and Full Year 2025 Financial Results
Fuente
United Therapeutics Corporation
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0